Accuneb (Inhalation)

Generic name:albuterol (inhalation route) [ al-BUE-ter-ol ]
Drug class:Adrenergic bronchodilators

Medically reviewed by Drugs.com. Last updated on Feb 19, 2022.

Commonly used brand name(s)

In the U.S.

• Accuneb
• ProAir Digihaler
• ProAir HFA
• Proair Respiclick
• Proventil
• Proventil HFA
• ReliOn Ventolin HFA
• Ventolin
• Ventolin HFA

In Canada

• Alti-Salbutamol Inhalation Aerosol
• Apo-Salvent
• Salbutamol
• Salbutamol Nebuamp
• Salbutamol Respirator Solution
• Ventolin Inhaler
• Ventolin Nebules P.F.
• Ventolin Respirator
• Ventolin Rotacaps

Available Dosage Forms:

• Powder
• Solution
• Suspension

Therapeutic Class: Bronchodilator

Pharmacologic Class: Beta-2 Adrenergic Agonist

Uses for Accuneb

Albuterol is used to treat or prevent bronchospasm in patients with asthma, bronchitis, emphysema, and other lung diseases. It is also used to prevent bronchospasm caused by exercise.

Albuterol belongs to the family of medicines known as adrenergic bronchodilators. Adrenergic bronchodilators are medicines that are breathed in through the mouth to open up the bronchial tubes (air passages) in the lungs. They relieve cough, wheezing, and trouble breathing by increasing the flow of air through the bronchial tubes.

This medicine is available only with your doctor's prescription.

Before using Accuneb

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of ProAir® Digihaler™, ProAir® HFA, ProAir® Respiclick®, Proventil® HFA, and Ventolin® HFA in children 4 years of age and older and Accuneb® in children 2 years of age and older. However, safety and efficacy have not been established for ProAir® Digihaler™, ProAir® HFA, ProAir® Respiclick®, Proventil® HFA, and Ventolin® HFA in children younger than 4 years of age and Accuneb® in children younger than 2 years of age.

Geriatric

Appropriate studies have not been performed on the relationship of age to the effects of Proventil® HFA in the geriatric population. However, elderly patients are more likely to have age-related heart problems, which may require caution in the dose for patients receiving Proventil® HFA.

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of ProAir® Digihaler™, ProAir® HFA,...